Entry into a Material Definitive Agreement. The Company on June 1, 2026 entered into an amended three-year $5,000,000 credit line facility (replacing the $5,000,000 facility (that we had entered into on March 19, 2023, and scheduled to expire July 13, 2026), drawdowns under which bear interest at the rate of 7% per annum. The credit line does not permit conversion by the lender of amounts outstanding under the line into common stock. The credit line provides the Company with financing, throug…

above in this report, The shares of Series A Preferred Stock issued in the dividend are held in accounts for the respective owners of the stock by Equinity Trust Company, LLC, the transfer agent for the Company’s common stock, as well as for the Series A Preferred Stock. The shares of Series A Preferred Stock is held by our transfer agent as restricted stock under SEC rules, and the shares held by the transfer agent are not issuable to or transferable by the recipients of the stock in the pre…

Regulation FD Disclosure. The Company announced on September 16, 2024 a share repurchase program to buy back up to $1,000,000 of its common stock. See Press Release attached as Exhibit 99.1.

Unregistered Sales of Equity Securities . Issuance of Stock Upon Conversion of Outstanding Note Pursuant to a Conversion Agreement dated May 14, 2024, TII Jet Services LDA (the “Holder”) agreed to convert $300,000 of the outstanding principal and accrued interest as of May 14, 2024, of the Creditline Promissory Note of the Company held by Holder ( as amended and restated as of July 13, 2023, the “Note”), into 76,230 shares of Common Stock, par value $0.001 per share, of the Company at a price…

Unregistered Sales of Equity Securities . Issuance of Stock Upon Conversion of Outstanding Note Pursuant to a Conversion Agreement dated May 14, 2024, TII Jet Services LDA (the “Holder”) agreed to convert $300,000 of the outstanding principal and accrued interest as of May 14, 2024, of the Creditline Promissory Note of the Company held by Holder (as amended and restated as of July 13, 2023, the “Note”) into 76,230 shares of Common Stock, par value $0.001 per share, of the Company at a price o…

Director — Sergei Glinka: Appointment of Sergei Glinka as a director of the Company.

Entry into a Material Definitive Agreement. On April 19, 2024, the Company completed an $8,400,000 equity financing with European investors (the “Offering”) of 2,100,000 units (“Units”), at a price of $4.00 per Unit, each Unit consisting of one share of common stock (“Shares”) and a Warrant to purchase two Shares of common stock (the “Warrants”). The Warrants have an exercise price of $6.43, are exercisable by payment of the exercise price in cash only and expire April 19, 2029, five years fr…

Unregistered Sales of Equity Securities . The following table sets forth the sales of unregistered securities since the Company’s last report filed under this item. Date Title and Amount (1) Purchaser Principal Underwriter Total Offering Price/ Underwriting Discounts March 20, 2024 Option to purchase 97,500 shares of common stock. Gareth Sheridan, Chief Executive Officer NA $2.61 per share/NA March 20, 2024 Option to purchase 97,500 shares of common stock. Serguei Melnik, President NA $2.61 p…

Other Events. Amendment to the Company’s Employee Stock Option Plan On March 20, 2024, our Board of Directors adopted an amendment to the Company’s 2021 Employees Stock Option Plan (the “Plan”) increasing the number of shares of common stock subject to the plan (as of March 20, 2024 875,000 shares) to 1,400,00 shares (the “Amendment”). The plan ado pted by the Board on November 1, 1921, provided for an initial 350,000 shares to issue and sell upon the exercise of stock options issued under th…

Unregistered Sales of Equity Securities . Issuance of Stock Upon Conversion of Outstanding Note Pursuant to a Conversion Agreement dated December 19, 2023, TII Jet Services LDA (the “Holder”) agreed to convert $2,000,000 of the outstanding principal and accrued interest as of December 19, 2023, of the Creditline Promissory Note of the Company held by Holder (as amended and restated as of July 13, 2023, the “Note”), into 1,026,720 shares of Common Stock, par value $0.001 per share, of the Comp…

Entry into a Material Definitive Agreement. The Company on July 13, 2023 entered into an amended three-year $5,000,000 credit line facility (replacing the $2,000,000 facility that we had entered into on March 19, 2023), drawdowns under which bear interest at the rate of 7% per annum. The credit line does not permit conversion by the lender of amounts outstanding under the line into common stock. The credit line provides the Company with financing, through the FDA approval process and into com…

Regulation FD Disclosure. The Company on March 19, 2023 entered into a three-year $2,000,000 credit line facility, drawdowns under which bear interest at the rate of 7% per annum. The credit line does not permit conversion by the lender of amounts outstanding under the line into common stock. The credit line provides the Company with financing, through the FDA approval process and into commercial scale manufacturing, for the Company’s patented lead product, AVERSA™ Fentanyl, an abuse-deterren…

Unregistered Sales of Equity Securities . The stock options issued to members of management and directors of the Company set forth below in

Issuance of stock options to directors and management.

Unregistered Sales of Equity Securities . The disclosures set forth below in

Issuance of stock options to directors and management.